“…For example, mice with a mutation knocking out one copy of the PPARg gene (PPARg +/À heterozygotes) [29], mice with a targeted disruption of the PPARg gene in macrophages (PPARg DMf ) [30], and mice that have a targeted disruption of the PPARg gene in the intestinal epithelium (PPARg DIEpC ) [31], all have increased susceptibility to chemically induced colitis. Similarly, mice that have both copies of the PPARa gene knocked out (PPARa À/ À homozygotes) have a worsened course of disease in several models for inflammatory and autoimmune disease, including chemically induced colitis [15], allergic asthma [32], carrageenan-induced edema and pleurisy [33], cerulein-induced pancreatitis [34], and EAE [35]. Remarkably, in all of these studies, a difference between control and PPAR-deficient mice in disease severity was observed in the absence of exogenously administered PPAR ligand, suggesting an anti-inflammatory role for either unliganded PPAR or PPAR bound to endogenous ligand(s).…”